Cognition Therapeutics In... (CGTX)
undefined
undefined%
At close: undefined
0.48
-1.19%
After-hours Dec 13, 2024, 07:37 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue - - - - -
Cost of Revenue 252.00K 235.00K 93.00K 98.00K 81.00K
Gross Profit -252.00K -235.00K -93.00K -98.00K -81.00K
Operating Income -50.72M -43.55M -28.60M -17.41M -17.83M
Interest Income 27.00K 22.22M 17.45M 10.86M 13.16M
Pretax Income -25.79M -21.40M -11.72M -7.84M -4.84M
Net Income -25.79M 757.00K -10.29M -10.07M -6.95M
Selling & General & Admin 13.53M 13.23M 10.03M 4.52M 3.45M
Research & Development 37.20M 30.32M 18.57M 12.89M 14.38M
Other Expenses - -22.22M -17.45M -10.86M -13.16M
Operating Expenses 50.72M 21.33M 11.15M 6.55M 4.67M
Interest Expense - 28.00K 893.00K 1.75M 1.02M
Selling & Marketing Expenses - - - - -
Cost & Expenses 50.72M 21.33M 11.15M 6.55M 4.67M
Income Tax - -22.15M -1.43M 2.23M 2.11M
Shares Outstanding (Basic) 29.99M 28.99M 22.23M 21.94M 21.94M
Shares Outstanding (Diluted) 30.03M 28.99M 22.23M 21.94M 21.94M
EPS (Basic) -0.86 0.03 -0.46 -0.46 -0.32
EPS (Diluted) -0.86 0.03 -0.46 -0.46 -0.32
EBITDA -25.51M -21.13M -13.38M -5.99M -3.50M
Depreciation & Amortization 252.00K 235.00K 93.00K 98.00K 81.00K